← Back
$PRLD All transactions

Prelude Therapeutics Inc

M

$ Value

Shares

9,375

Price

Filed

Jul 8

Insider

Name

Huang Jane

Title

President, CMO

CIK

0001683913

Roles

Officer

Transaction Details

Transaction Date

2025-07-04

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

84,252

Footnotes

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. | Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs. | The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

Filing Info

Accession No.

0001562180-25-005346

Form Type

4

Issuer CIK

0001678660

Huang Jane's History

Date Ticker Type Value
2025-07-04 PRLD M
2025-07-04 PRLD F $3K
2025-07-04 PRLD M $0
2025-06-12 TARA A $0

Other Insiders at PRLD (90d)

Insider Bought Sold Last
ORBIMED ADVISORS LLC / Bonita David P $12.5M 2026-04-21
BAKER BROS. ADVISORS LP $10.0M 2026-04-21